Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

Abstract Triggering cancer cell death by inducing DNA damage is the primary aim of radiotherapy; however, normal cells are also damaged. In this ...

Throughout the long history of human civilization, the exploration of science and the quest for truth have never ceased; technology continues to radiate a captivating charm. Opening the book "All ...